Ignite Creation Date:
2025-12-25 @ 12:45 AM
Ignite Modification Date:
2026-02-03 @ 4:37 PM
Study NCT ID:
NCT06846567
Status:
COMPLETED
Last Update Posted:
2025-02-27
First Post:
2025-02-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Study of BM2216 ER vs. Melogabalin Besilate: Safety, PK, and Food Effect in Healthy Adults
Sponsor:
Zhejiang Anglikang Pharmaceutical Co., Ltd.
Organization: